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Summary
 
To investigate the cellular dynamics of ZAP-70, we have studied the distribution and regula-
tion of its intracellular location using a ZAP-70 green fluorescent protein chimera. Initial ex-
periments in epithelial cells indicated that ZAP-70 is diffusely located throughout the quiescent
cell, and accumulates at the plasma membrane upon cellular activation, a phenotype enhanced
by the coexpression of Lck and the initiation of ZAP-70 kinase activity. Subsequent studies in
T cells confirmed this phenotype. Intriguingly, a large amount of ZAP-70, both chimeric and
endogenous, resides in the nucleus of quiescent and activated cells. Nuclear ZAP-70 becomes
tyrosine phosphorylated upon stimulation via the T cell receptor, indicating that it may have an
important biologic function.
 
T
 
he TCR has a multisubunit structure composed of the
polymorphic 
 
ab
 
 heterodimer, responsible for antigen
recognition, and the invariant CD3 
 
g
 
, 
 
d
 
, 
 
e
 
, and TCR-
 
z
 
subunits, required for receptor surface expression and signal
transduction. Engagement of the TCR leads to a rapid rise
in intracellular protein tyrosine phosphorylation, followed
by a series of other biochemical events, eventually resulting
in gene expression and effector function (for reviews see
references 1, 2). The earliest biochemical event after TCR
occupancy appears to be the activation of the Src family
protein tyrosine kinases (PTKs)
 
1
 
 Lck and/or Fyn. These acti-
vated kinases phosphorylate the various immunoreceptor
tyrosine-based activation motifs (ITAMs) of the TCR (3, 4),
providing binding sites for molecules containing SH2 do-
mains capable of binding phosphotyrosine in the proper con-
text (5). One such molecule is ZAP-70, also a PTK, which
binds via its tandem SH2 domains to the two phosphoty-
rosine residues of individual ITAMs (6, 7). Subsequent
phosphorylation of ZAP-70 by Lck and/or Fyn induces its
activation (3, 8, 9). Thereafter, a number of other signaling
and adaptor molecules are phosphorylated and recruited to
the activated TCR and ZAP-70, and may subsequently be
activated (10). These include phospholipase C
 
g
 
1 (PLC
 
g
 
1)
(11, 12), the proto-oncogenes Vav and Cbl (13, 14), and
SLP-76 and pp36 whose functions are still unknown (15).
Thus, a multicomponent protein complex is formed at the
TCR soon after activation, though the stoichiometry and
kinetics of assembly of its components have remained largely
unexplored.
A critical role for ZAP-70 in the initiation of T cell sig-
naling has been demonstrated by several lines of evidence.
For example, disruption of ZAP-70 recruitment to the acti-
vated TCR results in a loss of T cell signaling (16, 17). More-
over, a mutant Jurkat T cell line lacking ZAP-70, P116, shows
no functional or biochemical evidence of TCR-mediated ac-
tivation (B.L. Williams, manuscript in preparation) and pa-
tients with ZAP-70 mutations as well as ZAP-70 knockout
mice display profound SCID phenotypes (18–21). Despite
the information available regarding the function of ZAP-70
in T cells, little is known about its intracellular location or
dynamics. Upon cellular activation, ZAP-70 is rapidly ty-
rosine phosphorylated and it transiently translocates to the
TCR. However, subcellular fractionation experiments have
indicated that most ZAP-70 remains in the cytosol, and
only a fraction of the kinase becomes tyrosine phosphory-
lated when the cells are activated (W. Zhang, unpublished
observations). Though interest has focused on the TCR-
associated fraction of ZAP-70, clearly the function of the
majority of ZAP-70 molecules has been insufficiently ana-
lyzed.
To further explore ZAP-70 intracellular localization and
dynamics, we have used the green fluorescent protein (GFP)
of the jellyfish 
 
Aequorea victoria.
 
 The fluorescent signal gen-
 
1
 
Abbreviations used in this paper:
 
 cfb3, cytosolic fragment of erythrocyte
band 3; GFP, green fluorescent protein; IF, immunofluorescence; IP, im-
munoprecipitation; IRP, iron regulatory protein; ITAM, immunorecep-
tor tyrosine-based activation motif; KD, kinase dead; PTK, protein ty-
rosine kinase; PV, pervanadate; NLS, nuclear localization signal; ROI,
region of interest; RT, room temperature.
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erated by GFP is stable, species-independent, and can be mon-
itored noninvasively in living cells (22, 23). GFP-tagged
proteins have been used to assess the regulation of gene ex-
pression, the dynamics of intracellular organelles, and the
subcellular localization and movement of many proteins in
intact cells (see review in reference 23). Moreover, refined
GFP variants are now available, which are codon-optimized
for expression in mammalian cells and have fluorescence
intensities up to 35-fold higher than the wild-type GFPs (24).
Here we have used a chimeric protein composed of
ZAP-70 fused to the variant GFP, EGFP, as a tool to begin
to visually define the kinetics and regulation of ZAP-70
movement. Our results show that, when expressed in epi-
thelial cells, ZAP-70 GFP is found diffusely throughout the
quiescent cell. However, upon pharmacological stimulation,
redistribution of a pool of ZAP-70 GFP to the plasma mem-
brane occurs. This phenotype is enhanced by coexpression
of an active form of Lck (F505 Lck), but can occur in the
absence of any TCR chains. Although maximal membrane
accumulation requires full phosphorylation and activation
of ZAP-70 kinase, significant translocation of a kinase-dead
(KD) form of ZAP-70 GFP occurs. Subsequent studies in
T lymphocytes also indicate a cellular redistribution of the
enzyme upon activation via the TCR. Intriguingly, ZAP-70
GFP is present in the nucleus of both resting and activated
cells. This nuclear location was confirmed for the endoge-
nous protein in Jurkat T cells, both by immunofluores-
cence staining with an anti–ZAP-70 antiserum, and by bio-
chemical purification of the nuclear material. Similarly to
cytosolic ZAP-70, the nuclear pool demonstrates an in-
crease in phosphotyrosine content upon cellular stimulation,
implying that it acquires kinase activity (8, 9). Our observa-
tions provide visual evidence to support many previous
biochemical data, as well as revealing some unexpected
findings that will provoke further study. The movement of
ZAP-70 to the plasma membrane in the absence of a TCR
suggests that other peripheral or transmembrane proteins
can serve as docking molecules for this kinase. Moreover,
the presence of ZAP-70 in the nucleus leads one to reassess
its role as merely a plasma membrane PTK, suggesting in-
stead that it may have additional nuclear functions.
 
Materials and Methods
 
Cells, Antibodies, and Reagents.
 
Complete D10 (for Cos 7
cells) or R10 (Jurkat and its ZAP-70 negative mutant, P116) me-
dium was used for cell culture (8). The P116/ZAP-70 GFP sub-
clones C8, C11, and H9 were derived from the parent subclone
2G1, whereas F4 was derived from the independent parent subclone
1C2. All stably transfected lines were cultured in R10 complete
medium supplemented with 1 mg/ml Geneticin (G418; GIBCO
BRL, Gaithersburg, MD) for maintenance of transgene expression.
mAbs used include antiphosphotyrosine, 4G10 (UBI, Lake
Placid, NY); anti–TCR 
 
a
 
 chain, A2B4 (25); the F(ab
 
9
 
)
 
2
 
 fragment
of OKT3 (anti-CD3 
 
e
 
; reference 26); and anti-Lck, 3A5 (Santa
Cruz Biotechnology, Santa Cruz, CA). Rabbit sera are anti–ZAP-
70 (8), anti-GFP (Clontech, Palo Alto, CA), and anti–IRP-1 (27).
Rhodamine-coupled goat anti–mouse and goat anti–rabbit IgG
(Southern Biotechnology, Birmingham, AL), and Cy
 
TM
 
 3 donkey
anti–rabbit IgG (Jackson ImmunoResearch Labs Inc., West Grove,
PA) were used. The cytosolic fragment of erythrocyte band 3 (cfb3),
a substrate of ZAP-70, has been described elsewhere (28).
 
Plasmids and Constructs.
 
The generation of pSXSR
 
a
 
-Lck F505
has been described previously (8). An oligonucleotide linker method
was used to create the ZAP-70 GFP fusion protein expressed in
the Clontech pEGFP-N1 vector (pEGFP/ZAP-70). The oligo-
nucleotide, 5
 
9
 
-CTA GGG CCC CCA GGC AGC ACA CAG
AAG GCT GAG GCT GCC TGT GCC TCG-3
 
9
 
, encoding the
COOH terminus of ZAP-70, was cloned into the Xba 1/Bam
H1 sites of pBluescript KS plasmid. The Apa 1 fragment was sub-
cloned into pSXSR
 
a
 
-ZAP-Myc, and the EcoR1/BamH1 frag-
ment from this was subcloned into the corresponding sites of the
pEGFP-N1 expression vector. A KD form of ZAP-70, created by
site-directed mutagenesis of the lysine at position 369 to an ala-
nine, replaced ZAP-70 GFP in the pEGFP/ZAP-70 vector.
 
Transfection.
 
Cos 7 cells were electroporated using 15 
 
m
 
g of
each DNA construct at 250 V and 500 
 
m
 
F using a Gene Pulser
(Bio Rad Labs., Hercules, CA) and used at 20–26 h after transfec-
tion. P116 T cells (2 
 
3
 
 10
 
6
 
) were electroporated using 20 
 
m
 
g
DNA at 310 V and 500 
 
m
 
F. First stage subclones of P116/ZAP-
70 GFP, 2G1, and 1C2, were selected from a bulk population by
limiting dilution analysis, and these were further subcloned to
produce C8, C11, H9 (from 2G1), and F4 (from 1C2), respec-
tively.
 
Immunoprecipitation, Immunoblotting, Immune-complex Kinase As-
says, Cytosol/Membrane and Nuclear Fraction Purification.
 
Transfected
Cos 7 cells were harvested and lysed in Brij 97 lysis buffer (8). The
cells were stimulated for 10 min at room temperature (RT) in the
presence or absence of pervanadate (PV) before lysis. Jurkat, P116,
and ZAP-70 GFP subclones were left untreated or stimulated with
F(ab
 
9
 
)
 
2
 
 fragments of OKT3 for 2 min at 37
 
8
 
C before lysis. Post-
nuclear lysates were analyzed by SDS-PAGE or were subjected to
immunoprecipitation (IP) using the appropriate Ab adsorbed to
protein A–Sepharose. An immune-complex kinase assay was per-
formed using cfb3 as an exogenous substrate (1 
 
m
 
g/IP; reference 8).
For preparation of cytosolic/membrane and nuclear fractions,
Jurkat cells (4 
 
3
 
 10
 
7
 
) were suspended in homogenization buffer
(10 mM Tris, pH 7.6, 0.5 mM MgCl
 
2
 
, 1 mM PMSF, 10 
 
m
 
g/ml
Aprotinin, 10 
 
m
 
g/ml Leupeptin, 5 mM EDTA, 1 mM Na
 
3
 
VO
 
4
 
),
with (see Fig. 9 
 
a
 
) or without (see Fig. 9 
 
b
 
) 0.1% Tween 20, and
incubated on ice for 20 min. Swollen cells were then homoge-
nized by aspirating 50 times using a 25-gauge needle and 1-ml sy-
ringe, and the percentage of broken cells was 
 
.
 
95%. NaCl (150
mM final) and Hepes (pH 7.5, 50 mM final) were added, and
cells were centrifuged at 2,000 rpm for 5 min to pellet the nuclei.
Supernatants were considered the cytosolic/membrane fraction.
Nuclear pellets were washed three times with homogenization buf-
fer with (Fig. 9 
 
a
 
) or without (Fig. 9 
 
b
 
) 0.1% Triton X-100, resus-
pended in the same buffer (400 
 
m
 
l), and sonicated (four times, 30 s
each). Samples were boiled for 15 min, centrifuged at 15,000
rpm 
 
3
 
 10 min, and supernatants collected as purified nuclear ma-
terial. A portion of each cellular fraction was used to determine
enrichment of nuclear material and percent contamination from
cytosol. The remainder of each was immunoprecipitated with anti–
ZAP-70 antiserum after adding Brij 97 to 1% final concentration.
A densitometer (Molecular Dynamics, Sunnyvale, CA) and
ImageQuant software were used for quantitation analysis of auto-
radiographs.
 
Immunofluorescence Staining and Confocal Microscopy.
 
Transfected
Cos 7 cells were grown on sterile glass coverslips (10 or 25 mM
diameter, No. 1 thickness). ZAP-70 GFP subclones were adhered
to coverslips precoated with poly L-lysine (100 
 
m
 
g/ml; Sigma 
1715
 
Sloan-Lancaster et al.
Chemical Co., St. Louis, MO; see Figs. 5 and 6) for 2 h at 37
 
8
 
C.
Cells were stimulated directly on the coverslips (PV 
 
3
 
 10 min for
Cos 7 or F(ab
 
9
 
)
 
2
 
 of OKT3 
 
3
 
 2 min for 2G1), fixed in 2% formal-
dehyde in PBS for 15 min at RT, and examined directly or per-
meabilized and stained with the appropriate antibody. Antibody
staining was performed with T cells in suspension in all other ex-
periments, and cells were mounted onto coverslips immediately
before microscopy analysis. The cells were fixed using 3.7%
paraformaldehyde in PBS for 30 min at RT, washed (three times)
in PBS containing 10% fetal bovine serum (PBS/FBS), per-
meabilized using 0.1% Triton X-100 in PBS for 4 min at RT,
washed (three times), and incubated for 45 min in PBS/FBS for pre-
blocking. Cells were then incubated with first stage antibody (anti–
ZAP-70, anti-GFP, or anti-Lck) in PBS/FCS for 45 min at RT,
washed and incubated with second stage antibody (rhodamine-
coupled goat anti–mouse or anti–rabbit IgG or (see Fig. 7) Cy
 
TM
 
3 donkey anti–rabbit IgG) for 45 min, followed by washing with
PBS (three times). Cells were resuspended in Fluoromount G
added (Southern Biotechnology) and pipetted onto microscope
slides with a coverslip mounted on top. Hoechst stain (20 
 
m
 
g/ml)
was included during the second antibody incubation (See Fig. 7, 
 
c
 
and 
 
d
 
). These cells were viewed using a Zeiss Axioskop micro-
scope equipped with both UV and rhodamine optics and cells pho-
tographed directly. All other fixed cells were viewed as 0.5 
 
m
 
M
dual color optical sections, or composites of a complete Z section
analysis in (see Fig. 2) using a Zeiss lasor scanning microscope 410
confocal microscope having a 100 
 
3
 
 Zeiss planapo objective (nu-
merical aperature 1.4) and optics for both fluorescein (GFP) and
rhodamine (antibody stains). For experiments using live cells, the
coverslips were affixed to a Leiden coverslip dish and mounted on
a custom-made 37
 
8
 
C stage of the confocal microscope using the
100
 
3
 
 objective. The GFP molecule was excited with the 488 line of
a krypton-argon laser and imaged using a 515–540-nm bandpass
filter. Images were averaged 16 times to improve image quality. Two
images of each cell were taken before addition of stimulant, and
subsequent images were taken at 20-s intervals thereafter until 5 min
after stimulation, with the same cell slice being viewed in each image.
Quantitation measurements (see Fig. 6, 
 
c
 
 and 
 
d
 
) were deter-
mined using IP Lab Spectrum software. The middle section of a
complete Z series (0.5-
 
m
 
M slices) was selected from a field of
each subclone to ensure that a slice through the nucleus was be-
ing examined. Regions of interest (ROIs) were drawn around the
entire cell and around the nucleus, and the sum of pixels in each
ROI calculated. The following equation was used to determine
the percent of ZAP-70 GFP in the nucleus: (sum of intensities of
total pixels in nucleus)/(sum of intensities of total pixels in cell) 
 
3
 
100%. The mean fluorescence intensity for the entire cell is re-
ported to compare the expression level of ZAP-70 GFP between
individual cells.
 
Results
 
ZAP-70 GFP Chimera Retains the Antigenic and Kinase
Properties of Native ZAP-70.
 
The ZAP-70 GFP fusion
protein was constructed in a mammalian expression vector
fusing the GFP coding sequence to the COOH terminus of
ZAP-70 kinase (Fig. 1 
 
a
 
). To assess the enzymatic activity
of the chimeric protein, Cos 7 cells were transfected with
ZAP-70 GFP and Lck F505, left untreated, or stimulated
with PV, and an in vitro kinase assay was performed on the
anti–ZAP-70 IPs (Fig. 1 
 
b
 
, 
 
top
 
). Enzymatic activity was
measured by detection of autophosphorylation and phos-
phorylation of cfb3, a substrate for ZAP-70. ZAP-70 GFP
showed significant kinase activity, which was increased
upon cellular stimulation, indicating that the fusion protein
retained the enzymatic properties of the native ZAP-70
molecule (8). An anti–ZAP-70 immunoblot of the mem-
brane demonstrated the amounts of protein in the lanes and
confirmed that the antigenic properties of ZAP-70 had
been retained (Fig. 1 
 
b
 
, 
 
bottom
 
). Anti-GFP antiserum also
identified this single species (data not shown), whereas an
irrelevant mAb failed to IP the chimeric protein (Fig. 1 
 
b
 
).
 
ZAP-70 GFP Is Located throughout Cos 7 Cells, and Mi-
grates to the Plasma Membrane upon Activation.
 
Cos 7 cells
were next transfected with ZAP-70 GFP, and the fixed cells
were viewed using confocal microscopy. The kinase was
located diffusely throughout the cells, which frequently in-
cluded a heavy concentration in the perinuclear region, as
shown in Fig. 2 
 
a.
 
 Little, if any, plasma membrane–associ-
ated ZAP-70 was detected. Unexpectedly, marked nuclear
localization was also observed in many cells. Upon cellular
stimulation (Fig. 2 
 
b
 
, 
 
3 min PV
 
), ZAP-70 redistributed sig-
nificantly with cytosolic clearing and simultaneous accu-
mulation at the plasma membrane, indicating that there was
a correlation between ZAP-70 activation and its move-
ment to the cell surface.
Since Lck F505 induces ZAP-70 kinase activity (3, 8, 9),
we next examined if simply coexpressing the two proteins
resulted in more plasma membrane–associated ZAP-70. To
compare cellular distribution of the two enzymes, trans-
fected cells were immunostained with an anti-Lck antibody
and a rhodamine-coupled secondary mAb. Thus, the green
image represents ZAP-70, the red indicates Lck, and the
yellow image indicates where the two molecules colocal-
ize. Coexpression of active Lck had a dramatic influence on
the distribution of ZAP-70. A significant amount was ob-
served at the plasma membrane in the unstimulated cell,
and further rapid membrane accumulation occurred as soon
as 1 min after PV stimulation (Fig. 2, 
 
c
 
 and 
 
d
 
). Lck colocal-
ized at the plasma membrane with ZAP-70 in both in-
stances.
Figure 1. In vitro functional
activity and apparent molecular
weight of the ZAP-70 GFP fu-
sion protein. (a) Schematic of the
ZAP-70 GFP fusion protein,
showing the position of the GFP
(F64L, S65T) molecule at the
COOH terminus of ZAP-70,
with a predicted molecular
weight of z97 kD. (b) Cos 7
cells expressing pEGFP/ZAP-
70 and pSXSRaLck F505, were
incubated for 10 min with or
without PV as indicated. Immu-
noprecipitation of lysed cells was
performed with either anti–
ZAP-70 antiserum or A2B4 mAb,
and the phosphorlyated proteins
from an in vitro kinase assay ana-
lyzed (top). An anti–ZAP-70
Western blot of the same mem-
brane is shown (bottom). 
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Several intriguing observations were made from this ini-
tial experiment. ZAP-70 becomes closely associated with
the plasma membrane specifically upon activation, appar-
ently independent of the TCR, since Cos 7 cells do not
express any TCR components. In addition, the presence of
active Lck enhanced the membrane association of ZAP-70
GFP, suggesting that the phosphorylation and subsequent
activation of ZAP-70 are prerequisites for its translocation
to and association at the membrane. Furthermore, ZAP-70
was detected abundantly in the nucleus, a phenotype that
was unaffected by cellular stimulation.
 
Active Lck Enhances Plasma Membrane Accumulation of
ZAP-70.
 
Although it seemed that F505 Lck coexpression
enhanced ZAP-70 localization to the plasma membrane,
these observations were made using fixed cells, preventing
a comparison of the same cell at different stimulation time
points. To more accurately study the role of F505 Lck on
the quantitation and kinetics of ZAP-70 movement to the
cell surface, we monitored individual live cells over time,
both before and after stimulation. Transfected cells were
treated as described in Materials and Methods, and moni-
tored before and after PV stimulation, for a total of 5 min
after stimulation, with images taken at 20-s intervals. Upon
subsequent comparison of the images for ZAP-70 distribu-
tion, the kinetics of its movement to the plasma membrane
in a single cell could be visualized.
A representative cell, expressing ZAP-70 GFP alone,
was observed before and after stimulation with PV (Fig. 3,
 
top
 
). Consistent with the data acquired using fixed cells, the
unstimulated cell displayed a diffuse pattern of ZAP-70 ex-
pression, with only a small amount of fluorescence at the
plasma membrane (
 
unstim
 
). Upon pharmacologic stimula-
tion, little change in ZAP-70 distribution was apparent
during the first minute or so after stimulation (
 
1 min PV
 
).
However, after 2 min, plasma membrane accumulation of
ZAP-70 was evident (
 
2 min PV
 
, arrow highlights area of accu-
Figure 2. ZAP-70 GFP expression and cellular location in Cos 7 cells. Cos 7 cells expressing pEGFP/ZAP-70 alone (a and b) or together with pSXS-
RaLck F505 (c and d) were left untreated (a and c) or stimulated with pervanadate for 1 (d) or 3 min (b). Coverslips were mounted directly (a and b) or
after first staining with anti-Lck (c and d). The optical sections of a complete Z series were then projected to produce the composite single (a and b) or
dual (c and d) color images shown (green, ZAP-70 GFP fusion protein; red, immunostain of Lck F505). Areas of yellow represent colocalization of ZAP-
70 GFP and Lck F505 (c and d).1717 Sloan-Lancaster et al.
mulation). This redistribution to the cell surface steadily con-
tinued throughout the 5-min stimulation period (5 min PV).
A qualitatively different pattern was observed when cells
cotransfected with ZAP-70 GFP and F505 Lck were mon-
itored (Fig. 3, ZAP-70/F505). Unlike the cells transfected
with ZAP-70 GFP alone, those coexpressing F505 Lck con-
sistently showed a high concentration of perinuclear and in-
tranuclear ZAP-70, and minimal diffuse cytosolic location.
Moreover, a significant quantity of ZAP-70 was already at
the cell surface in the resting cell (unstim). Further accumu-
lation to the cell surface began immediately after PV addi-
tion (1 min PV), was rapidly and steadily enhanced with
the entire cell surface outlined by ZAP-70 GFP as early as 3
min before stimulation, and increased until the conclusion of
the experiment (5 min PV). Thus, active Lck has a dramatic
positive influence on the kinetics and quantity of ZAP-70
redistribution to the plasma membrane.
Redistribution of KD ZAP-70 to the Plasma Membrane Is
Highly Inefficient in Cos 7 Cells. Phosphorylation of spe-
cific tyrosine residues, and the subsequent activation of
ZAP-70 kinase, result from interaction with active Lck or
stimulation by PV (29). The phosphorylation and/or kinase
activation may be responsible for ZAP-70 translocation to
the plasma membrane. To determine whether an inactive
form of ZAP-70 would demonstrate the same dynamics, a
KD form of ZAP-70 (KD ZAP-70) was fused to GFP and
the chimera used in live cell experiments as above. When
expressed in Cos 7 cells alone, KD ZAP-70 GFP was abun-
dantly expressed in the cytosol, but not at the cell surface
(Fig. 3). Furthermore, PV stimulation had no effect on re-
distributing the protein at the early time points, in contrast
to the wild-type chimera (compare ZAP-70 and KD ZAP-
70, 1 min PV). At later time points, a small amount of KD
ZAP-70 could be seen around the cell surface (2, 3 min
PV, arrows indicate membrane accumulation), but this was
not enhanced as the cells were stimulated further (4, 5 min
PV). The addition of active Lck increased the redistribution
significantly (Fig. 3, bottom). As with the wild-type chi-
mera, some KD ZAP-70 was already at the cell surface in
the resting cell, although the quantity was much less (unstim).
Further movement to the membrane occurred after addi-
tion of PV, but again the total amount was less and the ki-
netics slower than with native ZAP-70. Thus, ZAP-70 ki-
nase activity is required for optimal redistribution to the
plasma membrane in TCR-negative epithelial cells.
Although the activation data suggest that Lck facilitates
ZAP-70 redistribution by phosphorylating and ultimately
activating it, a physical interaction between the two pro-
teins is also possible. Membrane association of ZAP-70 could
be mediated via this direct interaction since Lck associates
Figure 3. Effects of F505 Lck and cellular stimulation on the kinetics of plasma membrane acquisition of ZAP-70 GFP and KD ZAP-70 GFP. Individ-
ual live Cos 7 cells were examined by confocal microscopy and plasma membrane acquisition of ZAP-70 GFP assessed as described in Materials and
Methods. A single image of each cell is shown before activation (unstim) with subsequent images shown at 1-min intervals after the addition of PV. Ar-
rows highlight specific areas of plasma membrane accumulation of the ZAP-70 GFP fusion proteins.1718 ZAP-70 Intracellular Location
with the plasma membrane via its NH2-terminal myristyla-
tion site. Thus, we used a mutant form of F505 Lck in
which the myristylation site had been destroyed (30), and
determined its efficiency at facilitating ZAP-70 membrane
association. Transition of ZAP-70 to the cell surface was
similar regardless of whether Lck could associate with the
lipid bilayer, supporting the thesis that Lck kinase activity is
responsible for ZAP-70 movement (data not shown).
ZAP-70 GFP Reconstitutes Early Activation Events in P116
Cells Lacking ZAP-70. To study the intracellular location
and redistribution of ZAP-70 in T cells, we reconstituted a
mutant Jurkat T cell line, P116, which lacks ZAP-70 (Wil-
liams, B.L., and R.T. Abraham, manuscript submitted for
publication). Individual subclones were selected from stable
bulk cultures by limiting dilution analysis and two, 2G1 and
1C2, were used for further study. These lines were further
subcloned to derive C8, C11, H9 (from 2G1), and F4 (from
1C2). Anti–ZAP-70 IP and Western blot analysis (Fig. 4 a)
with subsequent densitometry measurements indicated that
the relative expression of ZAP-70 GFP compared to en-
dogenous ZAP-70 in Jurkat cells was 97% for C8, 143% for
C11, 131% for H9, and 94% for F4.
Jurkat, P116 cells and the stably reconstituted subclones
were left untreated or stimulated through the TCR with
OKT3 F(ab9)2 for 2 min at 378C. Ab-mediated TCR cross-
linking led to rapid increases in the phosphorylation of sev-
eral proteins in Jurkat T cells, as expected (Fig. 4 b). In
contrast, only a slight increase in tyrosine phosphorylated
substrates was observed in the stimulated P116 cells, consis-
tent with our previous observations (Zhang, W., B.L. Wil-
liams, and R.T. Abraham, unpublished data). The defect in
TCR-inducible protein tyrosine phosphorylation in P116
cells was reversed in all subclones, regardless of the level of
expression of ZAP-70 GFP (Fig. 4 b, and data not shown).
Thus, ZAP-70 GFP was able to reconstitute early signaling
events, which correlate with the kinetics of ZAP-70 local-
ization to the plasma membrane, in reconstituted P116 cells.
ZAP-70 GFP Redistributes Around the Cell Periphery in T
Cells After anti-TCR Stimulation. We next used the sub-
clones to determine the distribution of ZAP-70 in resting
and activated cells. 2G1 cells were stained with anti-Lck and
a rhodamine-coupled secondary mAb to colocalize the two
proteins. As expected, Lck was found exclusively around the
plasma membrane and in the cytosol, and provided a clear
counterstain surrounding the nucleus (Fig. 5 a). In contrast,
ZAP-70 GFP, while colocalizing with Lck in the cytosol
(yellow), was also abundant in the cell nucleus, displaying a
typical nucleolar exclusion pattern.
To assess if ZAP-70 redistribution to the plasma mem-
brane could be visualized in T cells, 2G1 cells were adhered
to coverslips and then fixed immediately or after stimula-
tion with OKT3 F(ab9)2 for 2 min (Fig. 5, b and c). Cyto-
plasmic ZAP-70 GFP was observed in the unstimulated
cells (b). In the population stimulated with anti-TCR anti-
body, some cells showed a peripheral rim of enhanced GFP
(Fig. 5 c, arrows), and others showed membrane blebs with
GFP (arrowhead). Whether this protein redistribution is
analogous to that seen in the Cos 7 cells is difficult to deter-
mine. Regardless, anti-TCR stimulation of T cells induces
rapid ZAP-70 redistribution, consistent with its movement
to and function at the plasma membrane.
Nuclear ZAP-70 GFP Location Is Independent of Protein
Expression Levels. ZAP-70 GFP was clearly identified in
the nucleus of the reconstituted subclones (Fig. 5). Al-
though the biochemical analysis showed that these cell lines
expressed comparable levels of ZAP-70 to Jurkat, the pos-
sibility remained that the nuclear ZAP-70 GFP was an arti-
fact of overexpression in individual cells. To rule this out,
we took advantage of the ability to quantitate the GFP fu-
sion protein by pixel intensity computation. Subclones F4
and H9 were selected as representatives expressing compa-
rable and 1.3-fold higher levels of ZAP-70 to endogenous
protein by biochemical analysis (see Fig. 4 a). A complete
Z series of adhered cells was carried out in several random
fields, and the middle section from each field was selected
for analysis to ensure that the nucleus was represented.
Quantitative measurements were taken of individual cells,
and the percent of ZAP-70 GFP in the nucleus deter-
mined. Data from a representative field of each subclone is
presented (Fig. 6).
Interestingly, although the cell lines had been subcloned
twice, a range of protein expression levels was observed in
each population, highlighting the sensitivity of the assay
system at the single cell level (Fig. 6, a and b). For F4, two
cells expressed ZAP-70 GFP at about the lowest level of
detection (Fig. 6 a, cells 1 and 2), reflected in the mean
pixel intensity for each cell (Fig. 6 c). Other cells in the F4
population expressed intermediate protein levels (e.g., cell
4). ROIs encompassing the entire cell and the nucleus were
quantified for total fluorescence intensity, and the percent
of ZAP-70 residing in the nucleus was determined using
the formula described in Materials and Methods. In most
cells, about half of the ZAP-70 detected in the section was
in the nucleus. More importantly, there was no correlation
between nuclear location and overall protein expression
Figure 4. Quantitation and
functional reconstitution analyses
of ZAP-70 GFP in stably trans-
fected P116 subclones. (a) Cell
lysates of Jurkat, P116, or P116/
ZAP-70 GFP subclones were
immunoprecipitated with anti–
ZAP-70. Immunoprecipitated
proteins were analyzed by SDS-
PAGE and Western blot using
anti–ZAP-70 (2 3 106 cells/
lane). Levels of ZAP-70 GFP ex-
pression in each subclone, pre-
sented as a percent of endoge-
nous ZAP-70 in Jurkat cells,
were as follows: 97% for C8,
143% for C11, 131% for H9, and
94% for F4. (b) Cells were lysed
directly or first stimulated for 2
min with OKT3 F(ab9)2 at 378C,
and antiphosphotyrosine West-
ern blot analysis of whole cellular
lysates (2 3 105 cells/lane) per-
formed.1719 Sloan-Lancaster et al.
levels (Fig. 6 c). This was further verified when the H9 sub-
clone was similarly assessed, whereas cells expressing much
higher total cellular amounts of ZAP-70 GFP showed no
significant increase in the amount residing in the nucleus
(Fig. 6, b and d, cells 7, 8, and 9). Thus, nuclear ZAP-70 is
not an artifact of overexpression since it exists at physiolog-
ical protein levels. It should be noted that, although close
to 50% of the material was nuclear in the slices quantitated,
this may not reflect the percent nuclear ZAP-70 in the en-
tire cell. To determine this value, the sum of values from all
slices through an individual cell must be calculated for a
population of cells.
Endogenous ZAP-70 Is Detected in the Nucleus of Jurkat
Cells by Immunofluorescence. To rule out the possibility that
nuclear ZAP-70 GFP was an artifact of the chimera, im-
munofluorescence (IF) staining was first performed on P116
cells reconstituted with ZAP-70 containing a COOH-ter-
minal Myc epitope tag. As with ZAP-70 GFP, nuclear
ZAP-70 was evident in about half of the cells (data not
shown). Next, an anti–ZAP-70 antiserum was affinity puri-
fied against its immunizing epitope and then used to iden-
tify the location of endogenous ZAP-70. Jurkat cells were
immunostained in suspension to maintain their three di-
mensional structure and eliminate the possibility of misin-
terpreting cellular location due to cell flattening. Immediately
after mounting, complete Z series analysis of immuno-
stained cells was performed. An assessment of the immuno-
staining pattern in all cell slices verified that endogenous
ZAP-70 is indeed present in the nucleus. Two slices (0.5-
mM–thick) through the middle of a typical field of Jurkat
cells, 1 mM apart, are displayed in Fig. 7 (a and b). The
staining pattern clearly indicates that ZAP-70 is not only in
the cytosol (note the intense peripheral staining), but also
highly abundant in the nucleus, with a typical nucleolar ex-
clusion pattern. The specificity of the staining pattern was
verified when ZAP-70–negative P116 cells, treated in a
similar manner, failed to show any IF staining (e), although
cells were present in the field as seen under the reflector
light (f). In addition, the secondary Ab alone did not sig-
nificantly stain the Jurkat cells (data not shown). The nu-
clear location of endogenous ZAP-70 was further confirmed
when Jurkat cells were costained with anti–ZAP-70 and a
Hoechst DNA stain. Although only the Ab stained the cy-
tosol, both anti–ZAP-70 and Hoechst showed a superim-
posable staining pattern in the nucleus (c and d). Thus, en-
dogenous ZAP-70 is present in the nucleus of normal
Jurkat T cells.
Efficiency of Ab Staining Is Hindered by the Nuclear Mem-
brane. A recent study reported that ZAP-70 is found ex-
Figure 5. Intracellular loca-
tion of ZAP-70 GFP in stably
transfected P116 T cells, and its
movement to the plasma mem-
brane upon cellular activation.
(a) Nuclear expression of ZAP-
70 GFP in P116/2G1 cells is
highlighted by the nucleolar ex-
clusion pattern. Endogenous Lck,
stained with anti-Lck and a
rhodamine-coupled secondary
mAb, is entirely extranuclear in
all cells, and areas of yellow indi-
cate the cytosolic colocalization
of ZAP-70 GFP and Lck. (b and c)
P116/2G1 cells were left un-
treated (b) or stimulated with
F(ab9)2 of OKT3 for 2 min at 378C
(c). Arrows and arrowheads indi-
cate peripheral rims and mem-
brane blebs of ZAP-70 GFP, re-
spectively (c).
Figure 6. Quantitation of nuclear ZAP-70 GFP, and its relationship to
expression levels, in individual cells of stably transfected P116 subclones.
The middle section from a complete Z series of 0.5 mM optical sections
through a field of F4 (a) and H9 (b) subclones is shown. Numbered cells
correlate with the corresponding quantitation analyses reported in (c) for
F4 and (d) for H9. Mean pixel intensity throughout individual cells is re-
ported as a method to accurately compare GFP expression levels between
cells. Percent nuclear ZAP-70 GFP was determined as described in Mate-
rials and Methods.1720 ZAP-70 Intracellular Location
clusively in a cortical region of Jurkat cells, with no evi-
dence of the protein in the nucleus (31). This is inconsistent
with the findings presented here. However, a comparison of
our results using Ab staining versus GFP to detect ZAP-70
revealed an interesting pattern that may explain this appar-
ent discrepancy. Although the ZAP-70 GFP was present
in the nucleus of all T cells examined, Ab staining using ei-
ther anti-Myc or anti-ZAP-70 consistently detected nu-
clear ZAP-70 in only about half of the cells, indicating that
some nuclear structure was acting as a physical barrier, pre-
venting efficient access of the Abs to the nucleus (data not
shown).
To formally test this hypothesis, Cos 7 cells expressing
ZAP-70 GFP were immunostained with either anti-GFP or
anti–ZAP-70 and a rhodamine-coupled secondary Ab. In-
dividual cells were then viewed, using dual-color optics for
fluorescein and rhodamine, to compare the location of
ZAP-70 using the two detection methods. A complete Z
series analysis was performed, and the center slice of a typi-
cal cell is shown for cells immunostained for GFP (Fig. 8,
a–c) or ZAP-70 (d–f). Although GFP indicated a high con-
centration of the chimera in the nucleus (Fig. 8 a), this was
completely unrecognized by the anti-GFP (Fig. 8 b). In
contrast, expression of the protein elsewhere in the cell was
detected comparably by either method (c, yellow indicates
overlay of both signals). Although the anti–ZAP-70 ap-
peared to be somewhat more accessible to the nucleus (e),
some exclusion was apparent since the GFP signal was
much stronger than the Ab signal (compare d, e, and over-
lay in f). The partial exclusion of anti–ZAP-70 is consistent
with the detection of only z50% of examined T cells dis-
playing nuclear ZAP-70 using this Ab. Our studies demon-
strate two strengths of the ZAP-70 GFP chimeric system. In-
tracellular locations of proteins, which are overlooked by
conventional IF techniques, are efficiently detected. Also,
accurate quantitative intracellular distribution measurements
can be made.
ZAP-70 Can Be Isolated from Jurkat Nuclei and Is Tyrosine
Phosphorylated after Anti-TCR Stimulation. To understand
the role of nuclear ZAP-70 in T cell signaling, a biochemi-
cal cell fractionation procedure was used to yield highly pu-
rified cytosol/membrane and nuclear pools from Jurkat cells.
ZAP-70 was abundant in both the cytosolic/membrane
and nuclear fractions, as indicated by anti–ZAP-70 immu-
noblotting of whole lysate preparations (Fig. 9 b, top). About
35% of total cellular ZAP-70 was nuclear, but this value
varied between experiments, a reflection of the inefficiency
of nuclear material recovery (32). The membrane was then
immunoblotted with anti–iron regulatory protein (IRP)-1
as a control for cytosolic contamination in the nuclear frac-
tion (Fig. 9 b, bottom), since IRP-1 is purely cytosolic (27,
33). Densitometric analysis indicated that the ratio of nu-
clear/cytosolic ZAP-70 was 0.53, whereas that for IRP-1
was 0.1. Thus, ZAP-70 in the nucleus was enriched 5.3-fold
as compared to IRP-1, and as much as 6.2-fold in other ex-
periments, confirming that ZAP-70 truly resides in the cell
nucleus. Similar results were found when nuclear material
Figure 7. Identification of endogenous ZAP-70 in the nucleus of Jur-
kat cells by IF staining. Jurkat (a, b, c, and d) and P116 (e and f) cells were
stained with affinity-purified anti–ZAP-70 antiserum. 0.5 mM slices
through the middle of the cells are displayed (a, b, e, and f). Two 0.5 mM
slices, 1 mM apart, are shown for anti–ZAP-70–stained Jurkat cells (a and
b), and one for P116 cells (e). An image of the same field as in e, using the
reflector optics, indicates the specificity of the Ab stain (f). The nuclear
staining of the anti–ZAP-70 is further verified by colocalization of anti–
ZAP-70 (c) with the Hoechst DNA stain (d) in the same cells.
Figure 8. Demonstration of inaccessibility of Abs to nuclei. Cos 7 cells,
expressing ZAP-70 GFP, were immunostained with anti-GFP (a–c) or
anti–ZAP-70 (d–f). ZAP-70 GFP (a and d), Ab signals (b and e) and the
dual-color overlays (c and f) are shown for a 0.5 mM slice through an in-
dividual cell stained with either anti-GFP (a–c) or anti–ZAP-70 (d–f).1721 Sloan-Lancaster et al.
was isolated from Jurkat cells in the presence (Fig. 9 a) or
absence (Fig. 9 b) of 0.1% mild detergent, and also in trans-
fected Cos 7 cells using a sucrose gradient separation tech-
nique (data not shown). Moreover, the enrichment of nu-
clear material was confirmed by immunoblotting with an
Ab against a nuclear pore complex protein (data not
shown; reference 34).
To compare the function of cytosolic and nuclear ZAP-
70, anti–ZAP-70 IPs of the purified cell fractions were per-
formed from unstimulated or OKT3 F(ab9)2 stimulated
cells, and the phosphotyrosine content examined. A spe-
cific increase in ZAP-70 phosphotyrosine content was ob-
served after anti-TCR stimulation, both in cytosolic and
nuclear ZAP-70 (Fig. 9 a, top). When compared to ZAP-
70 protein levels in the IPs (bottom), the increase in specific
activity was calculated to be 2.4-fold in the cytosolic frac-
tion and 1.4-fold in the nuclear fraction. P116 cells did not
contain any ZAP-70, although an unidentified nonspecific
species was present in the antiphosphotyrosine, but not anti–
ZAP-70, immunoblots which migrated more slowly than
the ZAP-70 protein (Fig. 9, top). Thus, nuclear ZAP-70
increases its phosphotyrosine content after anti-TCR stimu-
lation, and therefore likely acquires enzymatic activity. In-
terestingly, the insoluble material remaining after sonica-
tion of the nuclear/cytoskeletal pellet, which was separated
from the soluble nuclear material and considered to contain
cytoskeletal and nuclear matrix–associated proteins, showed
little or no evidence of ZAP-70 presence, either by direct
immunoblotting or by anti–ZAP-70 IP.
Discussion
Since the identification of ZAP-70 as a T cell–specific
protein tyrosine kinase, a number of biochemical studies have
focused on its activity, regulation, and molecular interac-
tions (for reviews see references 29, 35). Although such re-
search has been critical, a complementary cell biological
study is necessary to fully understand ZAP-70 function.
Here, we provide an analysis of ZAP-70 subcellular loca-
tion and demonstrate its dynamics under different condi-
tions. The visualization of ZAP-70 movement to the plasma
membrane supports previous biochemical data. Our work
also demonstrates that only a small fraction of total enzyme
translocates to the membrane. That this membrane localiza-
tion can be independent of TCR expression suggests that our
knowledge of the sequence of events occurring after T cell
stimulation may be incomplete. Moreover, the discovery
that there is a large pool of ZAP-70 in the nucleus, which
is activated upon cellular stimulation, suggests that the ki-
nase has additional, heretofore unexpected functions.
Compelling evidence exists indicating that a physical in-
teraction between ZAP-70 and TCR chains takes place soon
after T cell stimulation. Early studies showed that ZAP-70
coprecipitates with TCR-z and the CD3 chains after acti-
vation (36, 37). This interaction depends on the highly spe-
cific binding of the tandem SH2 domains of ZAP-70 with
tyrosine phosphorylated ITAMs of the TCR (6, 7). Our
results, revealing plasma membrane translocation of ZAP-
70 in the absence of any TCR chains, suggest that there are
alternative mechanisms of ZAP-70 localization at the plasma
membrane. Cos 7 cells may express a molecule at the sur-
face with cytoplasmic tyrosine residues or ITAMs, available
for phosphorylation and SH2 binding. SH2-mediated bind-
ing could also be independent of phosphotyrosine as seen
in the cases of Src family PTK SH2 domains binding to Raf
and other proteins, Abl SH2 binding Bcr and Syk SH2 do-
mains binding Cbl (38–40). However, the enhanced trans-
location of ZAP-70 to the membrane in response to per-
vanadate makes this possibility less likely. Thus, the kinase
can likely be retained at the membrane by additional, non-
SH2 mechanisms.
The tyrosine phosphorylation and subsequent activation
of ZAP-70 by Lck are the critical parameters in the facilita-
tion of its membrane localization. The observation that KD
ZAP-70 could redistribute to the cell surface less efficiently
than the native molecule suggests that ZAP-70 tyrosine phos-
phorylation or kinase activity is involved in the mechanism
of translocation. Perhaps a phosphorylation-dependent con-
formational change in ZAP-70 occurs leading to its activa-
tion and/or redistribution, similar to that reported for other
protein kinases (41–43). The activated kinase may then en-
hance the translocation either by increasing its own phos-
photyrosine content by transphosphorylation or that of down-
stream substrates which may then serve as vehicles for
ZAP-70 movement to the cell surface. We have found that
only about half of phospho–ZAP-70 is retrieved from the
membrane fraction of T cells. The rest is in the cytoplasm,
indicating that the enzyme may indeed be activated before
its accumulation at the cell surface (Zhang, W., unpublished
observations).
The majority of known protein tyrosine kinases are in-
volved in the transduction of extracellular signals, exerting
Figure 9. Biochemical isolation of ZAP-70 from nuclei of Jurkat cells,
and demonstration of its increased tyrosine phosphorylation after anti-
TCR stimulation. (a) Cytosol/membrane (1.2 3 107 cells) and nuclear
fractions (2.6 3 107 cells) of Jurkat or P116 cells, immunoprecipitated
with anti–ZAP-70, were analyzed by antiphosphotyrosine Western blot-
ting (top). The stripped membrane was reprobed with anti–ZAP-70 (bot-
tom). Specific activity of ZAP-70 after cellular stimulation was 2.4 for cy-
tosolic/membrane ZAP-70 and 1.4 for nuclear ZAP-70. A nonspecific
band appears in the 4G10 blot of P116 cells, which migrates more slowly
than the phosphorylated ZAP-70. (b) Whole lysate samples from the puri-
fied material (6 3 105 cells/lane) was immunoblotted with anti–ZAP-70,
and then reprobed with anti–IRP-1. Densitometric analysis confirmed
that there was a 5.3 fold enrichment of ZAP-70 in the nuclear fraction as
compared to IRP-1. This was confirmed in 3 independent experiments,
with enrichment of ZAP-70 as compared to IRP-n1 ranging from 5 fold
to 6.2 fold.1722 ZAP-70 Intracellular Location
their effects at or near the plasma membrane. The discov-
ery that several nuclear proteins contain phosphotyrosine
raised the possibility that some tyrosine kinases may reside
and have additional functions in the nucleus (for review see
reference 44). Indeed, several PTKs have a nuclear loca-
tion, the best characterized of which is c-Abl (44). This PTK
is found in both the cytoplasm and in the nucleus of cul-
tured fibroblasts, and has a classical nuclear localization sig-
nal (NLS) and a DNA binding domain. Kinase activity and
DNA binding of nuclear c-Abl is regulated during the cell
cycle (45). The significance of Abl cellular localization is
corroborated by the observation that oncogenic forms re-
side exclusively in the cytoplasm (45). Other nuclear PTKs
include two members of the Src family of PTKs, which can
be found in the nucleus as well as in the cytosol. The nu-
clear localization of Fgr appears to be constitutive, whereas
that of Src is induced by Ca21 ionophore (44). Two NLS
sequences have been identified in the SH2 and tyrosine ki-
nase domains of Fgr, but no analogous sites have yet been
discovered in Src. The specific nuclear functions of these
two kinases remains unknown (44).
Although unexpected, nuclear ZAP-70 was seen both as
a chimeric protein overexpressed in endothelial cells or at
physiological levels in T cells, and as the native endogenous
protein by immunofluorescence and biochemical analyses.
The advantages of using GFP chimeras to study cell local-
ization were highlighted in the comparison of the GFP and
immunofluorescence assay results. Ab detection of nuclear
ZAP-70 was hindered by the nuclear membrane, leading to
inaccurate results regarding the fraction of the molecule in
different cellular compartments, both within a single cell and
in the population as a whole. In contrast, the ZAP-70 GFP
protein, produced within the cell, was detected efficiently in
the nucleus of all cells, regardless of their expression levels.
Moreover, the ability to quantitate the amount of ZAP-70
GFP in individual cell fractions (46) facilitates the acquisi-
tion of accurate data regarding the percent of the protein in
different compartments under several stimulation conditions.
Preliminary biochemical results suggest that one third of
the total cellular ZAP-70 resides within the nucleus of rest-
ing T cells (Fig. 6). Finally, the ability to visually study GFP-
tagged proteins in living cells allows one to acquire precise
and detailed kinetic measurements regarding protein redis-
tribution in response to cellular stimulation, as shown by
the results in Fig. 3.
The details of ZAP-70 nuclear localization remain to be
defined. Because nuclear pores set a physical barrier to pro-
teins above z40 kD, transit of ZAP-70 into the nucleus
must be an active mechanism involving specific localization
signals (47). Although no classical NLSs are obvious in the
amino acid sequence, several candidate basic-rich regions
can easily be highlighted (37). Moreover, the recent dis-
covery of a novel receptor-mediated nuclear import path-
way, using a nonclassical NLS, suggest other mechanisms
for nuclear localization (48, 49). Interestingly, the lack of
an NH2-terminal myristylation may facilitate nuclear local-
ization of ZAP-70. Indeed, nuclear forms of Fgr lack the
conventional NH2-terminal myristylation site, and addition
of such a motif actually inhibits nuclear entry (45). The
function of nuclear ZAP-70 is likewise uncertain. How-
ever, the clear demonstration of its increased phosphoty-
rosine content after anti-TCR stimulation (Fig. 9) strongly
suggests that nuclear ZAP-70 is active. Indeed, many nu-
clear tyrosine phosphorylated proteins were apparent after
stimulation (data not shown), suggesting that nuclear PTKs
are active in the cells. Further investigation should reveal
informative data identifying which of these phosphorylated
proteins are substrates of nuclear ZAP-70. Finally, the mech-
anism of phosphorylation of nuclear ZAP-70 remains to be
defined. The protein may be phosphorylated in the cytosol
and subsequently shuttle into the nucleus, or alternatively
be activated directly in the nuclear compartment. The mech-
anism of nuclear ZAP-70 phosphorylation and the identity
of its nuclear substrates will require further investigation.
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